EVENT FREE SURVIVAL OF PATIENTS WITH MULTISYSTEM-RISK LANGERHANS CELL HISTIOCYTOSIS IS SUBOPTIMAL WITH LCH-III PROTOCOL: 8-YEARS CHANDIGARH, INDIA EXPERIENCE

PEDIATRIC BLOOD & CANCER(2015)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要